Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Capricor Therap
(NQ:
CAPR
)
6.850
+0.080 (+1.18%)
Streaming Delayed Price
Updated: 1:14 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
93,004
Open
6.740
Bid (Size)
6.840 (1)
Ask (Size)
6.850 (2)
Prev. Close
6.770
Today's Range
6.600 - 6.935
52wk Range
2.680 - 8.221
Shares Outstanding
31,399,667
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Recap: Capricor Therapeutics Q4 Earnings
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Performance
YTD
+33.79%
+33.79%
1 Month
+72.98%
+72.98%
3 Month
+34.84%
+34.84%
6 Month
+16.10%
+16.10%
1 Year
+67.07%
+67.07%
More News
Read More
Capricor Therapeutics's Earnings Outlook
February 28, 2024
Via
Benzinga
Preview: Capricor Therapeutics's Earnings
November 13, 2023
Via
Benzinga
FlexShopper And 3 Other Penny Stocks Insiders Are Buying
October 12, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
October 09, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Turn Lower; Dow Tumbles Over 200 Points
September 29, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recap: Capricor Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Preview For Capricor Therapeutics
March 14, 2023
Via
Benzinga
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 29, 2023
Via
Benzinga
Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge
September 29, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
September 29, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 29, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff
August 23, 2023
Via
Benzinga
Capricor Highlights Preclinical Data From Its Closed COVID-19 Vaccine Study
January 12, 2023
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
July 19, 2022
Via
Benzinga
Capricor Initiates Late-Stage Neuropsychiatric Disorder Study
July 19, 2022
Via
Benzinga
More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying
July 08, 2022
Via
Benzinga
7 Undervalued Penny Stocks With Major Upside
March 29, 2022
Via
InvestorPlace
50 Biggest Movers From Yesterday
March 29, 2022
Via
Benzinga
Mid-Afternoon Market Update: Dow Drops 150 Points; Capricor Therapeutics Shares Plunge
March 28, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.